Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Matsue
Kosei
K
Aoki
Takatoshi
T
Odawara
Jun
J
Kimura
Shun-ichi
S
Yamakura
Masayuki
M
Takeuchi
Masami
M
D000368:Aged; D000933:Antifibrinolytic Agents / Q000097:blood*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006471:Gastrointestinal Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate